Probity Advisors’s Clorox CLX Stock Holding History

Probity Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$554K	Buy	5,809 +847	+17%	+$81.3K	0.08%	155
2026 Q1	$514K	Buy	4,962 +1,303	+36%	+$148K	0.08%	153
2025 Q4	$369K	Buy	+3,659	New	+$397K	0.06%	183

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Probity Advisors's CLX Position: Q2 2026 in Review

Probity Advisors increased its Clorox (CLX) stake by 17% in Q2 2026, buying an estimated $81.3K and bringing the position to 5,809 shares worth $554K. The position accounts for 0.08% of the portfolio, ranked #155.

Probity Advisors first reported a position in CLX in Q4 2025 and has held it in 3 quarters since. 1,053 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Probity Advisors held 5,809 shares of Clorox worth $554K as of Q2 2026.
Probity Advisors bought 847 Clorox shares in Q2 2026, an estimated $81.3K.
Clorox made up 0.08% of Probity Advisors's portfolio in Q2 2026, its #155 holding.
Probity Advisors first reported a position in Clorox in Q4 2025 and has held it in 3 quarters since.
1,053 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.